Late-onset myasthenia gravis: A review when incidence in older adults keeps increasing
- 28 October 2013
- journal article
- review article
- Published by Wiley in Muscle & Nerve
- Vol. 48 (5) , 705-710
Abstract
We define late‐onset myasthenia gravis (LOMG) when symptoms appear at ≥65 years of age. There has been a continuous increase in the incidence of LOMG with a clear male predominance. Commonly, patients present with focal (ocular or bulbar) weakness. A high index of suspicion required to achieve early diagnosis and to improve prognosis. Management options include acetylcholinesterase inhibitors, steroids, and immunosuppressants. The most controversial issue in treatment is thymectomy, because not enough data are available. Successful treatment is associated with improved survival, and death is often secondary to comorbidities. Muscle Nerve 48:705–710, 2013Keywords
This publication has 60 references indexed in Scilit:
- Increasing incidence of myasthenia gravis among elderly in British Columbia, CanadaNeurology, 2011
- The thymus in myasthenia gravis: Site of “innate autoimmunity”?Muscle & Nerve, 2011
- Course and prognosis of myasthenia gravis: a systematic reviewEuropean Journal of Neurology, 2010
- HLA-DQ Polymorphism in Turkish Patients With Myasthenia GravisHuman Immunology, 2006
- Transsternal Thymectomy for Myasthenia Gravis: Surgical OutcomeThe Annals of Thoracic Surgery, 2006
- Myasthenia gravis in the elderly: a hospital based studyActa Neurologica Scandinavica, 1996
- Myasthenia GravisNew England Journal of Medicine, 1994
- Ocular myasthenia gravisDocumenta Ophthalmologica, 1993
- Preliminary Results of a Double-Blind, Randomized, Placebo-Controlled Trial of Cyclosporine in Myasthenia GravisNew England Journal of Medicine, 1987
- Diseases of the central nervous system. Myasthenia gravis.BMJ, 1975